Macrogenics (MGNX) Long-Term Investments (2016 - 2026)

Macrogenics (MGNX) has 11 years of Long-Term Investments data on file, last reported at $87.7 million in Q1 2026.

• Long-Term Investments for Q1 2026 came in at $87.7 million, up 923.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $87.7 million (up 923.36% YoY), and the FY2025 annual result was $132.7 million, up 604.82% from the prior year.
• Long-Term Investments eased to $87.7 million in Q1 2026 per MGNX's latest filing, from $132.7 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $166.5 million in Q3 2023 and troughed at $8.6 million in Q1 2025.
• A 5-year average of $77.6 million and a median of $66.3 million in 2025 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2025 and 2026: Long-Term Investments slumped 91.75% in 2025, then jumped 923.36% in 2026.
• A 5-year view of Long-Term Investments shows it stood at $45.5 million in 2022, then soared by 183.42% to $128.8 million in 2023, then slumped by 85.39% to $18.8 million in 2024, then surged by 604.82% to $132.7 million in 2025, then tumbled by 33.9% to $87.7 million in 2026.
• Business Quant data shows MGNX's Long-Term Investments at $87.7 million in Q1 2026, $132.7 million in Q4 2025, and $66.3 million in Q3 2025.